Related references
Note: Only part of the references are listed.New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy
Vittore Cereda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
James L. Gulley et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma
Weiyun Z. Ai et al.
BLOOD (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
Current prospects for mRNA gene delivery
Ayako Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Dendritic cell-based therapeutic cancer vaccines: what we have and what we need
Pawel Kalinski et al.
FUTURE ONCOLOGY (2009)
Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
Leisha A. Emens et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
Douglas G. McNeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
The cancer vaccine roller coaster
Bruce Goldman et al.
NATURE BIOTECHNOLOGY (2009)
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+T cell immune responses compared to intramuscular injection and intradermal gene gun delivery
Simon R. Best et al.
VACCINE (2009)
Phase 1/2 dose-escalation study of a GM-CSF-Secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
Celestial S. Higano et al.
CANCER (2008)
Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck
P. Michaluart et al.
CANCER GENE THERAPY (2008)
Combination of docetaxel and recombinant vaccine enhances T-Cell responses and antitumor activity: Effects of docetaxel on immune enhancement
Charlie T. Garnett et al.
CLINICAL CANCER RESEARCH (2008)
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation
Dan Laheru et al.
CLINICAL CANCER RESEARCH (2008)
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2008)
Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant
Robert J. Lechleider et al.
CLINICAL CANCER RESEARCH (2008)
Immune surveillance: a balance between protumor and antitumor immunity
Suzanne Ostrand-Rosenberg
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Heat-shock proteins as powerful weapons in vaccine development
Azam Bolhassani et al.
EXPERT REVIEW OF VACCINES (2008)
Clinical development of MVA-based therapeutic cancer vaccines
Bruce Acres et al.
EXPERT REVIEW OF VACCINES (2008)
Promises and challenges for the development of Listeria monocytogenes-based immunotherapies
Dirk G. Brockstedt et al.
EXPERT REVIEW OF VACCINES (2008)
Plasmid DNA- and messenger RNA-based anti-cancer vaccination
Benjamin Weide et al.
IMMUNOLOGY LETTERS (2008)
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 study group
Alessandro Testori et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
Ana Maria Hernandez et al.
JOURNAL OF IMMUNOLOGY (2008)
An adjuvant autologous therapeutic vaccine (HSPPC-96 vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentrel, open-label, randomised phase III trial
Christopher Wood et al.
LANCET (2008)
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
M. Campoli et al.
ONCOGENE (2008)
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
F. Stephen Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Specificity in cancer immunotherapy
Andrea Schietinger et al.
SEMINARS IN IMMUNOLOGY (2008)
GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action
Andrew D. Simmons et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4)
Junko Yokokawa et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Granulocyte macrophage colony-stimulating factor-secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer
Eric J. Small et al.
CLINICAL CANCER RESEARCH (2007)
The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy
Claudia Palena et al.
CLINICAL CANCER RESEARCH (2007)
A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients
Ryan D. Cassaday et al.
CLINICAL CANCER RESEARCH (2007)
Identification of T-cell epitopes for cancer immunotherapy
J. H. Kessler et al.
LEUKEMIA (2007)
Cooperation of Toll-like receptor signals in innate immune defence
Giorgio Trinchieri et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Vaccination with liposome-DNA complexes elicits enhanced antitumor immunity
L. U'Ren et al.
CANCER GENE THERAPY (2006)
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
Jon A. Kyte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
J. A. Kyte et al.
CANCER GENE THERAPY (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naive prostate cancer
JW Simons et al.
CLINICAL CANCER RESEARCH (2006)
The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells
SE Hamilton et al.
NATURE IMMUNOLOGY (2006)
Heat shock proteins as vaccine adjuvants in infections and cancer
Brahm H. Segal et al.
DRUG DISCOVERY TODAY (2006)
Sipuleucel-T (APC8015) for prostate cancer
Rosendo So-Rosillo et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
LJ Mu et al.
BRITISH JOURNAL OF CANCER (2005)
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer
C Butts et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Identification of novel human CTL Epitopes and their agonist epitopes of mesothelin
J Yokokawa et al.
CLINICAL CANCER RESEARCH (2005)
Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells
RJ Binder et al.
NATURE IMMUNOLOGY (2005)
Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
JA Kyte et al.
CANCER GENE THERAPY (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Yeasts encoding tumour antigens in cancer immunotherapy
A Franzusoff et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
CA Uyl-de Groot et al.
VACCINE (2005)
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer
Z Su et al.
JOURNAL OF IMMUNOLOGY (2005)
Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with stage 4 neuroblastoma
DA Caruso et al.
CANCER (2005)
Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy
GM Bendle et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1
KY Tsang et al.
CLINICAL CANCER RESEARCH (2004)
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
D Jocham et al.
LANCET (2004)
Highly efficient mRNA-based gene transfer in feeder-free cultured H9 human embryonic stem cells
P Ponsaerts et al.
CLONING AND STEM CELLS (2004)
Mesothelin-specific CD8+ T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients
AM Thomas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Messenger RNA-based vaccines
S Pascolo
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study
HS Pandha et al.
BJU INTERNATIONAL (2004)
Autologous dendritic cell vaccines for non-small-cell lung cancer
EA Hirschowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
DA Caruso et al.
NEURO-ONCOLOGY (2004)
Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results
WJ Lesterhuis et al.
ANNALS OF ONCOLOGY (2004)
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): A trial of the Eastern Cooperative Oncology group
HL Kaufman et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer
S Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA
MA Morse et al.
CANCER INVESTIGATION (2003)
Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer
J Gulley et al.
PROSTATE (2002)
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
A Heiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Share Paper
